Trials / Completed
CompletedNCT01692340
Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans
Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Ohio State University Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Tomatoes contain several compounds which may be beneficial for human health and prevention of disease, although this relationship is poorly understood and very controversial. This study uses a new technology to study the absorption and metabolism of three different compounds found in tomatoes. These compounds are called: phytoene, phytofluene, and lycopene. We hypothesize that by studying the absorption and metabolism of these compounds, we may be able to understand how the compounds may influence health and disease processes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Isotopically labeled lycopene, phytoene or phytofluene | We will administer 10 mg of labeled carotenoid mixed with olive oil and spread on an English muffin for consumption by participants. |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-09-25
- Last updated
- 2019-03-26
- Results posted
- 2015-10-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01692340. Inclusion in this directory is not an endorsement.